Ispire Technology Inc. (ISPR) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.08%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.63%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.08% | Research and development expense / revenue. Period ending 2026-06-30. $81.03K ÷ $96.01M × 100 ≈ 0.08% |
| Stock-based compensation / revenue · 12 months | 3.63% | Share-based compensation / revenue. Period ending 2026-06-30. $3.49M ÷ $96.01M × 100 ≈ 3.63% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 81.03K USD | Research and Development Expense |
| Revenue | 96.01M USD | |
| Stock-based compensation | 3.49M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -32.59M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $81.03K | $96.01M | $3.49M | $-32.59M | (m) | 0.08% | 3.63% | (m) | (m) |
| 2026-03-31 | (m) | $89.46M | $3.44M | $-33.70M | (m) | (m) | 3.85% | (m) | (m) |
| 2025-12-31 | (m) | $96.97M | $3.92M | $-34.80M | (m) | (m) | 4.05% | (m) | (m) |
| 2025-09-30 | (m) | $118.51M | $4.55M | $-35.28M | (m) | (m) | 3.84% | (m) | (m) |
| 2025-06-30 | $363.30K | $127.49M | $5.62M | $-37.85M | (m) | 0.28% | 4.41% | (m) | (m) |
| 2025-03-31 | (m) | $144.70M | $6.61M | $-26.65M | (m) | (m) | 4.57% | (m) | (m) |
| 2024-12-31 | (m) | $148.52M | $6.98M | $-21.72M | (m) | (m) | 4.70% | (m) | (m) |
| 2024-09-30 | (m) | $148.38M | $7.42M | $-18.28M | (m) | (m) | 5.00% | (m) | (m) |
| 2024-06-30 | $779.17K | $151.91M | $6.38M | $-13.89M | (m) | 0.51% | 4.20% | (m) | (m) |
| 2024-03-31 | (m) | $147.19M | (m) | $-11.52M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $141.32M | (m) | $-8.53M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $131.53M | (m) | $-4.27M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $115.61M | (m) | $-4.57M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $88.10M | (m) | $-988.67K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 22nd Century Group, Inc. (XXII) | United States | $0.001B | -0.53 |
| ALTRIA GROUP, INC. (MO) | United States | $115.012B | 15.07 |
| Philip Morris International Inc. (PM) | United States | $298.506B | 25.92 |